ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Scientists unveil CRISPR-based diagnostic platform – MIT News

Continue reading

2017-04-13 Michael Zand NEWS

A new CRISPR breakthrough could lead to simpler, cheaper disease diagnosis – Washington Post

Washington PostA new CRISPR breakthrough could lead to simpler, cheaper disease diagnosisWashington PostThe controversial laboratory tool known as CRISPR may have found a whole new world to conquer. Already the favored method of editing genes, CRISPR c… Continue reading

2017-04-13 Michael Zand NEWS

New CRISPR tool can detect tiny amounts of viruses – Science Magazine


MIT News

Scientists unveil CRISPR-based diagnostic platform
MIT News
Unlike DNA-targeting CRISPR enzymes (such as Cas9 and Cpf1), Cas13a can remain active after cutting its intended RNA target and may continue to cut other nontargeted RNAs in a burst of activity that Zhang lab scientists referred to as “collateral cleavage.

and more »

Continue reading

2017-04-13 Michael Zand NEWS

Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials – Xconomy

XconomyTocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer TrialsXconomyTocagen raised $85 million in its stock market debut today, and underwriters saw enough demand to increase the number of shares in the initial public offering. Tocagen has… Continue reading

2017-04-13 Michael Zand NEWS

University of California files appeal over CRISPR patents | Reuters – Reuters

ReutersUniversity of California files appeal over CRISPR patents | ReutersReutersThe University of California is appealing a U.S. patent ruling over the game-changing gene editing technology known as CRISPR that favored the Broad Institute&nbsp… Continue reading

2017-04-13 Michael Zand NEWS

University of California appeals patent setback, extending CRISPR fight – BioPharma Dive


The Verge

New CRISPR tool can detect tiny amounts of viruses
Science Magazine
This exquisitely sensitive and specific tool promises to help detect diseases that other diagnostics miss, and it’s simple and cheap to use. Sexier still, it exploits a variation of CRISPR, the genome-editing method that has become the rage in biology …
With a little detective work, CRISPR can say what that infection isThe Verge
A new CRISPR breakthrough could lead to simpler, cheaper disease diagnosisWashington Post
CRISPR cousin SHERLOCK may be able to track down diseases, scientists saySTAT
MIT News –The Scientist –New Scientist
all 7 news articles »
Continue reading

2017-04-13 Michael Zand NEWS

Locke Details Exciting Results for CAR T Cell Therapy in NHL – Targeted Oncology

Locke Details Exciting Results for CAR T Cell Therapy in NHLTargeted OncologyThe chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (KTE-C19) has shown promising results in patients with diffuse large B-cell lymphoma (DLBCL), primar… Continue reading

2017-04-13 Michael Zand NEWS

Bayer Ends Partnership with OncoMed on Compounds That Inhibit Cancer Stem Cell Pathways – Immuno-Oncology News

Bayer Ends Partnership with OncoMed on Compounds That Inhibit Cancer Stem Cell PathwaysImmuno-Oncology NewsEmail *. Website. Notify me of follow-up comments by email. Notify me of new posts by email. Search for: Receive our FREE Weekly Newsletter. * in… Continue reading

2017-04-13 Michael Zand NEWS
  • 1
  • …
  • 1,849
  • 1,850
  • 1,851
  • 1,852
  • 1,853
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

University of California appeals patent setback, extending CRISPR fight
BioPharma Dive
In mid-February, the Patent Trial and Appeal Board (PTAB) ruled that key patents held by the Broad on CRISPR-Cas9 do not overlap with competing claims from UC, effectively supporting the Broad’s existing patents for use of the technology in eukaryotic …